Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
After a person is diagnosed with bladder cancer, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes the extent (amount) of cancer in the body.
The stage of a bladder cancer is one of the most important factors in deciding how best to treat it and in determining how successful treatment might be.
To find the cancer’s stage, doctors try to answer these questions:
The stage of a bladder cancer is based on the results of physical exams, biopsies (from a cystoscopy or TURBT), and imaging tests (CT or MRI scan, x-rays, etc.), which are described in Tests for Bladder Cancer. The results of surgery (a partial or radical cystectomy), if it has been done, can also be used to help determine the stage of the cancer.
A staging system is a standard way for the cancer care team to describe how far a cancer has spread. The staging system most often used for bladder cancer is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced.
Once a person’s T, N, and M categories have been determined, usually after surgery, this information is combined in a process called stage grouping to assign an overall stage. The earliest stage (non-invasive) cancers are stage 0, and then range from stages I (1) through IV (4).
As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means a more advanced cancer. And within a stage, an earlier letter means a lower stage (for example, stage IIIA is less advanced than stage IIIB).
Cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
There are 2 types of staging for bladder cancer:
The staging system in the table below describes the pathological stages for bladder cancer. (More information about the TNM categories follows the stage table.)
Bladder cancer staging can be complex. If you have any questions about your stage, please ask your doctor to explain it to you in a way you understand.
Stage |
Stage grouping |
Stage description |
0a |
Ta N0 M0 |
The cancer is a non-invasive papillary carcinoma (Ta). It has grown toward the hollow center of the bladder but has not grown deeper into the connective tissue or muscle of the bladder wall (see image below). It has not spread to nearby lymph nodes (N0) or distant parts of the body (M0). |
0is |
Tis N0 M0 |
The cancer is a flat, non-invasive carcinoma (Tis), also known as carcinoma in situ (CIS). The cancer is growing in the inner lining layer of the bladder only. It has not grown inward toward the hollow part of the bladder, nor has it invaded deeper into the connective tissue or muscle of the bladder wall. It has not spread to nearby lymph nodes (N0) or distant parts of the body (M0). |
I |
T1 N0 M0 |
The cancer has grown into the layer of connective tissue under the lining layer of the bladder, but it has not reached the layer of muscle in the bladder wall (T1). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
II |
T2a or T2b N0 M0 |
The cancer has grown into the inner (T2a) or outer (T2b) muscle layer of the bladder wall, but it has not passed completely through the muscle to reach the layer of fatty tissue that surrounds the bladder. The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IIIA |
T3a, T3b or T4a N0 M0 |
The cancer has grown through the muscle layer of the bladder and into the layer of fatty tissue that surrounds the bladder (T3a or T3b). It might have spread into the prostate, seminal vesicles, uterus, or vagina, but it's not growing into the pelvic or abdominal wall (T4a). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
T1-4a N1 M0 |
The cancer has at least grown into the layer of connective tissue under the lining of the bladder wall (and may have grown farther), but it's not growing into the pelvic or abdominal wall (T1-T4a), AND the cancer has spread to 1 nearby lymph node in the true pelvis (N1). It has not spread to distant parts of the body (M0). |
|
IIIB
|
T1-T4a N2 or N3 M0 |
The cancer has at least grown into the layer of connective tissue under the lining of the bladder wall (and may have grown farther), but it's not growing into the pelvic or abdominal wall (T1-T4a), AND the cancer has spread to 2 or more lymph nodes in the true pelvis (N2) or to lymph nodes along the common iliac arteries (N3). It has not spread to distant parts of the body (M0). |
IVA |
T4b Any N M0
|
The cancer has grown through the bladder wall into the pelvic or abdominal wall (T4b).
It might or might not have spread to nearby lymph nodes (Any N). It has not spread to distant parts of the body (M0). |
OR |
||
Any T Any N M1a |
The cancer might or might not have grown through the wall of the bladder and into nearby organs (Any T). It might or might not have spread to nearby lymph nodes (Any N). It has spread to distant lymph nodes (M1a). |
|
IVB |
Any T Any N M1b |
The cancer might or might not have grown through the wall of the bladder and into nearby organs (Any T). It might or might not have spread to nearby lymph nodes (Any N). It has spread to 1 or more distant organs, such as the bones, liver, or lungs (M1b). |
The T category describes how far the main tumor has grown into the wall of the bladder (or beyond).
The wall of the bladder has 4 main layers.
Nearly all bladder cancers start in the lining or urothelium. As the cancer grows into or through the other layers in the bladder, it becomes more advanced (the stage goes up).
The T categories are described in the table above, except for:
TX: Main tumor cannot be assessed due to lack of information
T0: No evidence of a primary tumor
The N category describes spread only to the lymph nodes near the bladder (in the true pelvis) and those along the blood vessel called the common iliac artery. These lymph nodes are called regional lymph nodes. Any other lymph nodes are considered distant lymph nodes. Spread to distant nodes is considered metastasis (described in the M category). Surgery is usually needed to find cancer spread to lymph nodes, since this is seldom seen on imaging tests.
The N categories are described in the table above, except for:
NX: Regional lymph nodes cannot be assessed due to lack of information.
N0: There's no regional lymph node spread.
The M categories are described in the table above.
For treatment purposes, bladder cancers are typically divided into 2 main groups:
NMIBC is often further divided into low-, intermediate-, and high-risk groups. This is based on factors such as:
Doctors use these risk groups to get an idea of how likely it is that a bladder cancer will come back or progress further, which in turn might affect a person’s treatment options.
The risk groups for NMIBC can be complex. If you have NMIBC and want to know more, ask your doctor to explain your risk group to you in a way you understand.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Joint Committee on Cancer. Urinary Bladder. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 757-765.
Kassouf W, Black P. Treatment of primary non-muscle invasive urothelial bladder cancer. UpToDate. 2023. Accessed at https://www.uptodate.com/contents/treatment-of-primary-non-muscle-invasive-urothelial-bladder-cancer on November 9, 2023.
Lotan Y, Choueiri TK. Clinical presentation, diagnosis, and staging of bladder cancer. UpToDate. 2023. Accessed at https://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-of-bladder-cancer on November 2, 2023.
National Cancer Institute. Bladder Cancer Stages. 2023. Accessed at https://www.cancer.gov/types/bladder/stages on November 2, 2023.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 3.2023. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf on November 9, 2023.
Last Revised: March 12, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.